Drug intelligence / Profile preview

urea + propylene glycol

Development stage
Unknown
Lead developer
Galenica
Modality
Small Molecules
Administration
Topical
01

Overview

urea + propylene glycol (G001) is a fixed-dose combination topical cream developed by Galenica AB, containing 5% urea and 20% propylene glycol. It is primarily indicated for the treatment of dry skin (xerosis) and the prevention of relapse in patients with atopic dermatitis. Urea acts as a potent humectant by increasing the water-binding capacity of the stratum corneum and exhibits keratolytic properties by softening keratin, which facilitates the exfoliation of dry, scaly skin. Propylene glycol serves as a complementary humectant and solvent, enhancing skin hydration and acting as a penetration enhancer to improve the efficacy of urea. This combination is specifically designed to strengthen the skin's natural barrier function and prolong the flare-free interval in individuals prone to atopic eczema.

Brand names
Urea/Propylenglykol Galenica
Other names
Urea/Propylene Glycol GalenicaKarbamid/Propylenglykol GalenicaUrea 5% + Propylene Glycol 20% Cream

Beyond the preview

Go deeper on urea + propylene glycol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on urea + propylene glycol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call